Clinical Trials Sponsored by Allermed Laboratories, Inc.
Total 453 results
-
University of ArkansasAllermed Laboratories, Inc.Completed
-
Alkermes, Inc.CompletedSchizophrenia | Bipolar I Disorder | Schizophreniform DisordersUnited States, Korea, Republic of, Russian Federation, Ukraine, Austria, Germany, Ireland, Israel, Italy, Poland, Spain, United Kingdom
-
Alkermes, Inc.TerminatedRefractory Major Depressive DisorderUnited States, Puerto Rico, Australia
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Puerto Rico, Australia
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Australia, Canada
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Canada, Germany, Puerto Rico, Bulgaria, Australia, Poland, Hungary
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Alkermes, Inc.CompletedOpiate DependenceRussian Federation
-
Alkermes, Inc.Completed
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedOpioid DependenceUnited States
-
Alkermes, Inc.TerminatedLaparoscopic SurgeryUnited States
-
Alkermes, Inc.CompletedDental PainUnited States
-
Alkermes, Inc.CompletedBinge Eating DisorderUnited States
-
Alkermes, Inc.CompletedOpioid-induced ConstipationUnited States
-
Alkermes, Inc.RecruitingSchizophrenia | Bipolar I DisorderUnited States, Argentina, Mexico, Brazil, Colombia
-
Alkermes, Inc.Enrolling by invitationSchizophrenia | Bipolar I DisorderUnited States, Argentina, Brazil, Colombia, Mexico
-
Alkermes, Inc.CompletedSchizophrenia | Schizophreniform Disorder | Bipolar I DisorderUnited States, Bulgaria, Russian Federation, Ukraine, Austria, Ireland, Israel, Italy, Korea, Republic of, Poland, United Kingdom, Serbia, Puerto Rico
-
Alkermes, Inc.CompletedBipolar I DisorderUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Puerto Rico
-
Alkermes, Inc.Terminated
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Puerto Rico
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States, Canada, Germany, Puerto Rico
-
Alkermes, Inc.CompletedA Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)Major Depressive DisorderUnited States, Canada
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.CompletedOpiate DependenceUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Ukraine, Serbia
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Korea, Republic of, Malaysia, Philippines, Romania, Russian Federation, Ukraine
-
Alkermes, Inc.CompletedPharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal FunctionRenal ImpairmentUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedHealthyUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.Completed
-
Alkermes, Inc.Completed
-
Alkermes, Inc.CompletedMajor Depressive DisorderUnited States
-
Alkermes, Inc.Completed
-
Alkermes, Inc.Completed
-
Alkermes, Inc.RecruitingNarcolepsy Type 1United States
-
Alkermes, Inc.CompletedFocus of Study is on Healthy Lactating WomenUnited States
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Alkermes, Inc.Terminated
-
Alkermes, Inc.CompletedSchizophrenia | Alcohol Use DisorderUnited States, Bulgaria, Poland
-
Alkermes, Inc.CompletedSchizophreniaUnited States, Bulgaria, Ukraine, Serbia